FIELD: chemistry.
SUBSTANCE: invention relates to pyrrole derivatives of formula I: , where values of R1-R4, R7, R8 are given in claim 1. Compounds of formula I exhibit antagonistic activity on MR steroid receptors, which enables their use to produce a pharmaceutical composition and drugs with MR steroid receptor antagonist properties.
EFFECT: improved method.
95 cl, 26 dwg, 2 tbl, 32 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED CHROMANS | 2015 |
|
RU2718060C2 |
NOVEL CONDENSED PYRIDINE DERIVATIVES USED AS C-MET TYROSINE KINASE INHIBITORS | 2013 |
|
RU2619130C2 |
AZEPINOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS | 2004 |
|
RU2423363C2 |
PYRROLO[2,1-A]ISOQUINOLINES | 2009 |
|
RU2495037C2 |
COMPOUNDS AND METHODS OF INHIBITING INTERACTION OF BCL PROTEINS WITH BINDING COMPONENTS | 2006 |
|
RU2424230C2 |
ION CHANNEL INHIBITORS, PHARMACEUTICAL FORMULATIONS AND APPLICATIONS | 2016 |
|
RU2746188C2 |
METHOD FOR TREATMENT OF ALLERGY BY USING SUBSTITUTED PYRAZOLES | 2001 |
|
RU2259202C2 |
NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES USEFUL AS PLASMA KALLIKREIN INHIBITOR | 2014 |
|
RU2712621C2 |
PYRAZOLPYRIMIDINE COMPOUNDS JAK INHIBITORS AND METHODS | 2009 |
|
RU2539568C2 |
SUBSTITUTED PYRAZOLES | 2001 |
|
RU2286343C2 |
Authors
Dates
2012-12-27—Published
2005-07-30—Filed